vs
Side-by-side financial comparison of Campbell's Company (The) (CPB) and GE HealthCare (GEHC). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.1B vs $2.7B, roughly 1.9× Campbell's Company (The)). GE HealthCare runs the higher net margin — 8.0% vs 7.2%, a 0.8% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.4% vs -3.4%). GE HealthCare produced more free cash flow last quarter ($112.0M vs $97.0M). Over the past eight quarters, Campbell's Company (The)'s revenue compounded faster (4.4% CAGR vs 3.0%).
The Campbell's Company is an American company, most closely associated with its flagship canned soup products. The classic red-and-white can design used by many Campbell's branded products has become an American icon, and its use in pop art was typified by American artist Andy Warhol's series of Campbell's Soup Cans prints.
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
CPB vs GEHC — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.7B | $5.1B |
| Net Profit | $194.0M | $411.0M |
| Gross Margin | 29.6% | 38.5% |
| Operating Margin | 12.6% | 10.0% |
| Net Margin | 7.2% | 8.0% |
| Revenue YoY | -3.4% | 7.4% |
| Net Profit YoY | -11.0% | -31.0% |
| EPS (diluted) | $0.65 | $0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $5.1B | ||
| Q4 25 | $2.7B | $5.7B | ||
| Q3 25 | $2.3B | $5.1B | ||
| Q2 25 | $2.5B | $5.0B | ||
| Q1 25 | $2.7B | $4.8B | ||
| Q4 24 | $2.8B | $5.3B | ||
| Q3 24 | $2.3B | $4.9B | ||
| Q2 24 | $2.4B | $4.8B |
| Q1 26 | — | $411.0M | ||
| Q4 25 | $194.0M | $588.0M | ||
| Q3 25 | $145.0M | $446.0M | ||
| Q2 25 | $66.0M | $486.0M | ||
| Q1 25 | $173.0M | $564.0M | ||
| Q4 24 | $218.0M | $721.0M | ||
| Q3 24 | $-3.0M | $470.0M | ||
| Q2 24 | $133.0M | $428.0M |
| Q1 26 | — | 38.5% | ||
| Q4 25 | 29.6% | 39.7% | ||
| Q3 25 | 30.4% | 38.7% | ||
| Q2 25 | 29.4% | 39.6% | ||
| Q1 25 | 30.5% | 42.1% | ||
| Q4 24 | 31.3% | 42.8% | ||
| Q3 24 | 29.4% | 41.7% | ||
| Q2 24 | 30.9% | 41.4% |
| Q1 26 | — | 10.0% | ||
| Q4 25 | 12.6% | 14.5% | ||
| Q3 25 | 11.6% | 12.7% | ||
| Q2 25 | 6.5% | 13.1% | ||
| Q1 25 | 12.2% | 13.2% | ||
| Q4 24 | 13.2% | 15.1% | ||
| Q3 24 | 3.4% | 13.9% | ||
| Q2 24 | 10.5% | 12.6% |
| Q1 26 | — | 8.0% | ||
| Q4 25 | 7.2% | 10.3% | ||
| Q3 25 | 6.2% | 8.7% | ||
| Q2 25 | 2.7% | 9.7% | ||
| Q1 25 | 6.4% | 11.8% | ||
| Q4 24 | 7.9% | 13.6% | ||
| Q3 24 | -0.1% | 9.7% | ||
| Q2 24 | 5.6% | 8.8% |
| Q1 26 | — | $0.85 | ||
| Q4 25 | $0.65 | $1.28 | ||
| Q3 25 | $0.49 | $0.98 | ||
| Q2 25 | $0.22 | $1.06 | ||
| Q1 25 | $0.58 | $1.23 | ||
| Q4 24 | $0.72 | $1.58 | ||
| Q3 24 | $-0.01 | $1.02 | ||
| Q2 24 | $0.44 | $0.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $168.0M | — |
| Total DebtLower is stronger | $6.1B | $10.1B |
| Stockholders' EquityBook value | $4.0B | $10.7B |
| Total Assets | $15.2B | $37.1B |
| Debt / EquityLower = less leverage | 1.54× | 0.95× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $168.0M | $4.5B | ||
| Q3 25 | $132.0M | $4.0B | ||
| Q2 25 | $143.0M | $3.7B | ||
| Q1 25 | $829.0M | $2.5B | ||
| Q4 24 | $808.0M | $2.9B | ||
| Q3 24 | $108.0M | $3.5B | ||
| Q2 24 | $107.0M | $2.0B |
| Q1 26 | — | $10.1B | ||
| Q4 25 | $6.1B | $10.0B | ||
| Q3 25 | $6.1B | $10.3B | ||
| Q2 25 | $6.1B | $10.3B | ||
| Q1 25 | $6.5B | $8.8B | ||
| Q4 24 | $6.7B | $9.0B | ||
| Q3 24 | $5.8B | $10.3B | ||
| Q2 24 | $5.8B | $9.2B |
| Q1 26 | — | $10.7B | ||
| Q4 25 | $4.0B | $10.4B | ||
| Q3 25 | $3.9B | $10.0B | ||
| Q2 25 | $3.9B | $9.7B | ||
| Q1 25 | $3.9B | $9.2B | ||
| Q4 24 | $3.8B | $8.4B | ||
| Q3 24 | $3.8B | $8.3B | ||
| Q2 24 | $3.9B | $7.8B |
| Q1 26 | — | $37.1B | ||
| Q4 25 | $15.2B | $36.9B | ||
| Q3 25 | $14.9B | $36.1B | ||
| Q2 25 | $14.8B | $35.5B | ||
| Q1 25 | $15.9B | $33.6B | ||
| Q4 24 | $16.1B | $33.1B | ||
| Q3 24 | $15.2B | $33.9B | ||
| Q2 24 | $15.2B | $31.9B |
| Q1 26 | — | 0.95× | ||
| Q4 25 | 1.54× | 0.96× | ||
| Q3 25 | 1.56× | 1.03× | ||
| Q2 25 | 1.58× | 1.06× | ||
| Q1 25 | 1.66× | 0.95× | ||
| Q4 24 | 1.75× | 1.06× | ||
| Q3 24 | 1.52× | 1.24× | ||
| Q2 24 | 1.47× | 1.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $224.0M | — |
| Free Cash FlowOCF − Capex | $97.0M | $112.0M |
| FCF MarginFCF / Revenue | 3.6% | 2.2% |
| Capex IntensityCapex / Revenue | 4.7% | — |
| Cash ConversionOCF / Net Profit | 1.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $687.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $224.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $135.0M | $94.0M | ||
| Q1 25 | $512.0M | $250.0M | ||
| Q4 24 | $225.0M | — | ||
| Q3 24 | $288.0M | — | ||
| Q2 24 | $213.0M | $-119.0M |
| Q1 26 | — | $112.0M | ||
| Q4 25 | $97.0M | — | ||
| Q3 25 | $129.0M | — | ||
| Q2 25 | $50.0M | $8.0M | ||
| Q1 25 | $411.0M | $98.0M | ||
| Q4 24 | $115.0M | — | ||
| Q3 24 | $147.0M | — | ||
| Q2 24 | $100.0M | $-183.0M |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 3.6% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 2.0% | 0.2% | ||
| Q1 25 | 15.3% | 2.1% | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 4.2% | -3.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.7% | 2.4% | ||
| Q3 25 | 5.6% | 2.1% | ||
| Q2 25 | 3.4% | 1.7% | ||
| Q1 25 | 3.8% | 3.2% | ||
| Q4 24 | 4.0% | 1.9% | ||
| Q3 24 | 6.1% | 1.9% | ||
| Q2 24 | 4.8% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.15× | — | ||
| Q3 25 | 1.79× | — | ||
| Q2 25 | 2.05× | 0.19× | ||
| Q1 25 | 2.96× | 0.44× | ||
| Q4 24 | 1.03× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.60× | -0.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CPB
| Baked Snacks | $995.0M | 37% |
| Snacks | $914.0M | 34% |
| Simple Meals | $580.0M | 22% |
| Beverages | $168.0M | 6% |
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
